Acarix announces enrollment of first patient in US-based Clinical Workflow Evaluation Study
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce the enrollment of the first patient in its...
Acarix welcomes Jeff Thomas as new Head of US Sales
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announces the appointment of Jeff Thomas as the new Head of US Sa...
Acarix CPT III Code Removed from United Healthcare Medicare Advantage Noncovered List
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announces effective May 1, 2024, that the CADScor System CPT III ...
Announcement from the annual general meeting in Acarix AB
The annual general meeting 2024 (the "AGM") of Acarix AB ("Acarix" or the "Company") was held today on 14 May 2024 and the following re...
Kommuniké från årsstämma i Acarix AB
Årsstämman 2024 i Acarix AB ("Acarix" eller "Bolaget") hölls idag den 14 maj 2024 varvid aktieägarna fattade f&oum...
Acarix secures a multi-unit order from major cardiology practice with several offices in Florida
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, has announced that the CADScor System is now available at multipl...
Invitation to presentation of Acarix´s first quarter report
Acarix will publish its first quarter results on Tuesday 14 May 2024 at 08.00 am (CEST). A live webcast will be held at 15.00 (CEST) th...
CADScor System is now being utilized by Leading Cardiology Practice in the New York Capital Region
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the integration of the CADScor System at Capital Cardiology ...
Proposal by the nomination committee prior to the 2024 annual general meeting of Acarix AB (publ)
The Nomination Committee of Acarix consists of Jan Poulsen (Chairman) representing Life Science Invest Fund 1 among others, Anton Rehns...
Acarix receives order from the first freestanding Emergency Room in the US
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the CADScor System has been added to the diagnostic tools av...
NOTICE OF ANNUAL GENERAL MEETING IN ACARIX AB
The shareholders of Acarix AB, reg. no. 559009-0667 (the "Company"), are hereby invited to the annual general meeting on Tuesday 14 May...
KALLELSE TILL ÅRSSTÄMMA I ACARIX AB
Aktieägarna i Acarix AB, org.nr 559009-0667 ("Bolaget"), kallas härmed till årsstämma tisdagen den 14 maj 2024 kl....